Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Kåre Schultz
Kåre Schultz
Oxford Biomedica's next CEO to start in March; Kåre Schultz ready to wrap up Teva tenure early
Endpoints
Wed, 11/23/22 - 07:36 am
Pharma CEOs
Frank Mathias
Oxford BioMedica
Kåre Schultz
Teva Pharmaceutical
Richard Francis
As CEO Schultz eyes retirement, Teva taps former Sandoz head Francis as its next leader
Fierce Pharma
Mon, 11/21/22 - 10:30 am
Pharma CEOs
Teva Pharmaceutical
Kåre Schultz
Richard Francis
Sandoz
Teva CEO Schultz likely won't renew employment contract next year: reports
Fierce Pharma
Mon, 09/19/22 - 09:57 pm
Teva Pharmaceutical
Kåre Schultz
Pharma CEOs
Teva expects to start paying U.S. opioid settlement in 2023
Reuters
Mon, 09/19/22 - 09:41 am
Teva Pharmaceutical
opioids
opioid crisis
Kåre Schultz
Teva CEO Kåre Schultz brought home $14.7M last year, soaring past some of Europe's top-paid pharma execs
Endpoints
Mon, 03/21/22 - 10:10 am
Teva Pharmaceuticals
Pharma CEOs
Kåre Schultz
executive pay
Teva execs claim mixed winning streak in pricey opioids court battle — as permanent peace remains elusive
Endpoints
Wed, 02/9/22 - 10:57 pm
Teva Pharmaceutical
earnings
Kåre Schultz
legal
opioids
Teva CEO Kåre Schultz sees a 35% raise despite the company's continued legal woes
Endpoints
Thu, 04/22/21 - 10:58 am
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
executive pay
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too
Fierce Pharma
Wed, 03/25/20 - 12:10 am
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
executive pay
After years of business and lawsuit-fueled decline, is a Teva turnaround in sight?
Endpoints
Thu, 02/13/20 - 10:52 am
Teva Pharmaceutical
Kåre Schultz
Teva CEO says manufacturing cuts will keep coming even after $3B reduction achieved
Fierce Pharma
Tue, 08/13/19 - 10:31 am
Teva Pharmaceutical
Kåre Schultz
Pharma CEOs
drug manufacturing
Revenue plunges, stock takes a drubbing, but Teva CEO Kåre Schultz still grabs $32.5M in chart-topping compensation
Endpoints
Tue, 04/16/19 - 07:51 pm
Teva Pharmaceutical
Kåre Schultz
Pharma CEOs
executive pay
Kare Schultz, Teva CEO, announces new data showing the worst phase is now over
GoinPharma
Thu, 01/10/19 - 09:52 am
Teva Pharmaceutical
debt
JPMHC 2019
Kåre Schultz
Pharma CEOs
Teva implements impressive recovery strategy
GoinPharma
Wed, 06/27/18 - 08:55 pm
Teva Pharmaceutical
Kåre Schultz
restructuring
Teva joins the executive pay big leagues after doling out $17M to new CEO Kare Schultz
Fierce Pharma
Fri, 03/30/18 - 05:57 pm
Teva Pharmaceutical
executive pay
Kåre Schultz
Pharma CEOs
Teva chief reports 'strong progress' in restructuring plan
CNBC
Sat, 02/10/18 - 09:27 am
Teva Pharmaceutical
restructuring
layoffs
Kåre Schultz
Pharma CEOs
Time for weighing things up for Kare Schultz, Teva CEO: group gains $8bn in capitalization in two months
GoinPharma
Mon, 01/1/18 - 03:08 pm
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
Teva's new launches won't feel the sting of hefty cost cuts: CEO
Fierce Pharma
Mon, 12/18/17 - 11:25 am
Teva Pharmaceutical
drug launches
Pharma CEOs
Kåre Schultz
layoffs
Austedo
fremanezumab
Roiled by financial turmoil, Teva’s CEO boots R&D chief, top execs in C-suite overhaul
Endpoints
Mon, 11/27/17 - 10:44 am
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
R&D
executives
Teva R&D chief out as new CEO picks up the ax and aims at deep cuts to rescue a faltering biopharma — report
Endpoints
Fri, 11/24/17 - 11:36 am
Teva Pharmaceutical
R&D
layoffs
Kåre Schultz
Hard times for Teva Pharmaceutical
GoinPharma
Thu, 10/5/17 - 09:33 am
Teva Pharmaceutical
Copaxone
Kåre Schultz
Pages
1
2
next ›
last »